[HTML][HTML] Animal models of brain-first and body-first Parkinson's disease

N Van Den Berge, A Ulusoy - Neurobiology of disease, 2022 - Elsevier
Alpha-synuclein aggregates are the hallmark pathology of Parkinson's disease, which can
propagate in a stereotypical pattern along the brain-body axis. Parkinson's disease patients …

α‐Synuclein Radiotracer Development and In Vivo Imaging: Recent Advancements and New Perspectives

OM Alzghool, G van Dongen… - Movement …, 2022 - Wiley Online Library
ABSTRACT α‐Synucleinopathies including idiopathic Parkinson's disease, dementia with
Lewy bodies and multiple systems atrophy share overlapping symptoms and pathological …

Structures of α-synuclein filaments from human brains with Lewy pathology

Y Yang, Y Shi, M Schweighauser, X Zhang, A Kotecha… - Nature, 2022 - nature.com
Parkinson's disease (PD) is the most common movement disorder, with resting tremor,
rigidity, bradykinesia and postural instability being major symptoms. Neuropathologically, it …

[HTML][HTML] Alpha-synuclein immunization strategies for synucleinopathies in clinical studies: a biological perspective

L Knecht, J Folke, R Dodel, JA Ross, A Albus - Neurotherapeutics, 2022 - Elsevier
The therapeutic strategies currently available for neurodegenerative diseases such as
Parkinson's disease target only the symptoms of the disease. Parkinson's disease, dementia …

Neuropathology of α‐synuclein in Parkinson's disease

CJ Choong, H Mochizuki - Neuropathology, 2022 - Wiley Online Library
Parkinson's disease (PD) is a neurodegenerative disorder characterized by progressive
movement disability accompanied by non‐motor symptoms. The neuropathology hallmark of …

[HTML][HTML] Role of post-translational modifications on the alpha-synuclein aggregation-related pathogenesis of Parkinson's disease

H Yoo, J Lee, B Kim, H Moon, H Jeong, K Lee… - BMB …, 2022 - ncbi.nlm.nih.gov
Together with neuronal loss, the existence of insoluble inclusions of alpha-synuclein (α-syn)
in the brain is widely accepted as a hallmark of synucleinopathies including Parkinson's …

Second sphere interactions in amyloidogenic diseases

M Roy, AK Nath, I Pal, SG Dey - Chemical Reviews, 2022 - ACS Publications
Amyloids are protein aggregates bearing a highly ordered cross β structural motif, which
may be functional but are mostly pathogenic. Their formation, deposition in tissues and …

[HTML][HTML] Neuronal cell death mechanisms in Alzheimer's disease: An insight

P Goel, S Chakrabarti, K Goel, K Bhutani… - Frontiers in molecular …, 2022 - frontiersin.org
Regulated cell death (RCD) is an ordered and tightly orchestrated set of changes/signaling
events in both gene expression and protein activity and is responsible for normal …

Structural Determinant of β-Amyloid Formation: From Transmembrane Protein Dimerization to β-Amyloid Aggregates

N Papadopoulos, N Suelves, F Perrin, DM Vadukul… - Biomedicines, 2022 - mdpi.com
Most neurodegenerative diseases have the characteristics of protein folding disorders, ie,
they cause lesions to appear in vulnerable regions of the nervous system, corresponding to …

Ferritinophagy and α-Synuclein: pharmacological targeting of autophagy to restore iron regulation in Parkinson's disease

MK Boag, A Roberts, VN Uversky, L Ma… - International journal of …, 2022 - mdpi.com
A major hallmark of Parkinson's disease (PD) is the fatal destruction of dopaminergic
neurons within the substantia nigra pars compacta. This event is preceded by the formation …